ESSA Pharma
EPIX
EPIX was delisted on the 8th of October, 2025.
36 hedge funds and large institutions have $50.1M invested in ESSA Pharma in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 12 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
2.65% less ownership
Funds ownership: 74.03% → 71.37% (-2.7%)
15% less capital invested
Capital invested by funds: $58.8M → $50.1M (-$8.76M)
22% less funds holding
Funds holding: 46 → 36 (-10)
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$327K |
| 2 |
DAM
DLD Asset Management
New York
|
+$311K |
| 3 |
AC
Aldebaran Capital
Carmel,
Indiana
|
+$291K |
| 4 |
JP Morgan Chase
New York
|
+$279K |
| 5 |
DCM
Deuterium Capital Management
Clearwater,
Florida
|
+$187K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$1.99M |
| 2 |
ACM
Altium Capital Management
New York
|
-$639K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$324K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$193K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$130K |
EPIX Hedge Fund Activity: Q1 2025 in Review
36 of the 7,470 institutional investors tracked by Wall St. Rank reported a position in ESSA Pharma (EPIX) for Q1 2025, worth a combined $50.1M — down 15% from $58.8M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of EPIX and 3 opened new positions — a net loss of 9 holders — while 10 trimmed existing stakes and 7 added.
The largest buyer was Two Sigma Advisers, adding an estimated $327K. The largest seller was RTW Investments, exiting entirely with an estimated $1.99M sold.
- 36 institutional investors held ESSA Pharma (EPIX) as of Q1 2025, down from 46 in Q4 2024.
- Funds reported $50.1M of ESSA Pharma stock for Q1 2025, down 15% quarter-over-quarter.
- 3 funds opened new ESSA Pharma positions in Q1 2025 and 12 closed out, a net change of -9 holders.
- The largest ESSA Pharma buyer in Q1 2025 was Two Sigma Advisers, an estimated $327K added.
- The largest ESSA Pharma seller in Q1 2025 was RTW Investments, an estimated $1.99M sold.
Based on aggregated 13F filings for Q1 2025.